Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2018 | 06-2017 | 06-2016 | 06-2015 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -13,831 | -11,994 | 15,460 | -47,580 |
| Depreciation Amortization | N/A | 2,305 | 2,331 | 3,080 | 12,770 |
| Accounts receivable | N/A | 1,130 | 930 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 850 | -367 | N/A | N/A |
| Other Working Capital | N/A | -472 | 1,343 | 850 | 570 |
| Other Operating Activity | 9,463 | -1,489 | -977 | -1,160 | 8,410 |
| Operating Cash Flow | $9,463 | $-11,506 | $-8,735 | $18,230 | $-25,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -650 | -236 | -998 | -200 | -160 |
| Purchase Sale Intangibles | -36 | -309 | -8 | N/A | N/A |
| Other Investing Activity | -36 | -309 | -8 | -20 | -120 |
| Investing Cash Flow | $-685 | $-545 | $-1,006 | $-220 | $-280 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,197 | -1,126 | -1,054 | N/A | N/A |
| Other Financing Activity | -162 | -171 | -195 | -1,490 | -1,240 |
| Financing Cash Flow | $-1,359 | $-1,298 | $-1,249 | $-1,490 | $-1,240 |
| Exchange Rate Effect | N/A | 1 | 113 | 190 | 30 |
| Beginning Cash Position | 16,672 | 29,560 | 39,442 | 28,620 | 58,710 |
| End Cash Position | 24,091 | 16,212 | 28,566 | 45,320 | 31,380 |
| Net Cash Flow | $7,419 | $-13,348 | $-10,877 | $16,700 | $-27,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,463 | -11,506 | -8,735 | 18,230 | -25,830 |
| Capital Expenditure | -651 | -236 | -1,000 | N/A | N/A |
| Free Cash Flow | 8,812 | -11,742 | -9,734 | 18,230 | -25,830 |